Paragon 28 Inc
NYSE:FNA
Operating Margin
Paragon 28 Inc
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| US |
P
|
Paragon 28 Inc
NYSE:FNA
|
1.1B USD |
-16%
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
215.6B USD |
17%
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
174.4B USD |
28%
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
136.5B USD |
18%
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
132.9B USD |
22%
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
105.9B USD |
19%
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
57.7B USD |
14%
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
48.2B EUR |
13%
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
40.2B USD |
27%
|
|
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
261.4B CNY |
36%
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
31.2B USD |
29%
|
Paragon 28 Inc
Glance View
Paragon 28, Inc. engages in operation of an orthopedic foot and ankle company. The company is headquartered in Englewood, Colorado and currently employs 343 full-time employees. The company went IPO on 2021-10-15. The firm develops, distributes and markets medical devices in the foot and ankle segment of the orthopedic implant marketplace. The firm has developed a range of foot and ankle surgical systems and procedural techniques designed to address the primary conditions requiring treatment in the foot and ankle including fracture fixation, hallux valgus bunions, hammertoe, ankle, progressive collapsing foot deformity (PCFD) or flatfoot, Charcot foot, and orthobiologics. The products used in foot and ankle procedures include screws, wires and pins, plates, nails, fixators, staples, joint implants, soft tissue implants, orthobiologics and other implantation instruments and disposables. The firm has developed approximately 6,600 implant, 1,200 instrument, and 900 disposable and other stock keeping units (SKU’s). The company has commercial footprint across United States and International.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Paragon 28 Inc's most recent financial statements, the company has Operating Margin of -15.9%.
You don't have any saved screeners yet